These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17037299)

  • 1. [High risk pathophysiology and the molecular mechanism of arteriosclerosis].
    Yamada N
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1667-75. PubMed ID: 17037299
    [No Abstract]   [Full Text] [Related]  

  • 2. [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP].
    Robichon C; Girard J; Postic C
    Med Sci (Paris); 2008 Oct; 24(10):841-6. PubMed ID: 18950580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
    Ferré P; Foufelle F
    Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid synthetic transcription factor, SREBP].
    Hitoshi S
    Nihon Rinsho; 2005 May; 63(5):897-907. PubMed ID: 15881188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What have we learned thanks to genetics in type II diabetes and its complications?].
    Froguel P
    Nephrologie; 1999; 20(2):59-63. PubMed ID: 10227025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral hypoglycemic agents, present and future].
    Shimano H
    Nihon Yakurigaku Zasshi; 2006 Jul; 128(1):42-5. PubMed ID: 16948200
    [No Abstract]   [Full Text] [Related]  

  • 7. TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes.
    Nakagawa Y; Shimano H; Yoshikawa T; Ide T; Tamura M; Furusawa M; Yamamoto T; Inoue N; Matsuzaka T; Takahashi A; Hasty AH; Suzuki H; Sone H; Toyoshima H; Yahagi N; Yamada N
    Nat Med; 2006 Jan; 12(1):107-13. PubMed ID: 16327801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic syndrome and insulin resistance].
    Ura N; Saito S; Shimamoto K
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1716-20. PubMed ID: 17037304
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diabetes and the metabolic syndrome].
    Yamauchi T; Kadowaki T
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):133-40. PubMed ID: 16971775
    [No Abstract]   [Full Text] [Related]  

  • 10. [Life style-related diseases--from the etiological mechanism to prevention].
    Kobayashi T; Saito I; Yamada N; Nakamura T; Matsuzawa Y; Shibaike N
    Nihon Naika Gakkai Zasshi; 2001 Feb; 90 Suppl():90-3. PubMed ID: 11307342
    [No Abstract]   [Full Text] [Related]  

  • 11. Healthy lifestyles and health promotion: a challenge and an opportunity for nutrition science.
    O'Dea K
    Forum Nutr; 2003; 56():100-3. PubMed ID: 15806817
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transcription factor, TFE3 improves metabolic syndrome].
    Nakagawa Y; Shimano H
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():790-6. PubMed ID: 21766698
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
    Yoshida D; Higashiura K; Shimamoto K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():533-7. PubMed ID: 15779436
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice.
    Suzuki M; Kakuta H; Takahashi A; Shimano H; Tada-Iida K; Yokoo T; Kihara R; Yamada N
    J Atheroscler Thromb; 2005; 12(2):77-84. PubMed ID: 15942117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in clinical care of cardiovascular diseases complicated with diabetes mellitus].
    Sone H; Yamada N
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):794-801. PubMed ID: 19472542
    [No Abstract]   [Full Text] [Related]  

  • 16. Obesity.
    Bush EN
    Endocrine; 2006 Feb; 29(1):1-3. PubMed ID: 16622286
    [No Abstract]   [Full Text] [Related]  

  • 17. [The metabolic syndrome and insulin resistance].
    Kotani K; Kaku K
    Nihon Rinsho; 2005 Aug; 63(8):1485-91. PubMed ID: 16101244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanism of insulin resistance].
    Tobe K; Nemoto S; Kadowaki T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():114-30. PubMed ID: 15779355
    [No Abstract]   [Full Text] [Related]  

  • 19. SREBPs suppress IRS-2-mediated insulin signalling in the liver.
    Ide T; Shimano H; Yahagi N; Matsuzaka T; Nakakuki M; Yamamoto T; Nakagawa Y; Takahashi A; Suzuki H; Sone H; Toyoshima H; Fukamizu A; Yamada N
    Nat Cell Biol; 2004 Apr; 6(4):351-7. PubMed ID: 15048126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy for metabolic syndrome].
    Node K
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1737-41. PubMed ID: 17037308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.